Find and Pitch Jounalists, Get Your Story Covered

Tags: brain cancer, cancer, glioblastoma, immunotherapy cranberry recurrent febrile nitrofurantoin

	Profile	Recent Articles on Subject
1	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	SABCS 2024: The Persistent Association Between Obesity and Breast Cancer Outcomes - 10 days ago
2	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - 14 days ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show - 29 days ago Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer - 9 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - 10 months ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - 12 months ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - about 1 year ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - about 1 year ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - about 1 year ago Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - about 1 year ago
4	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger - about 1 month ago Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 4 months ago STAT+: AI drug firm Recursion seeks to move from survival to industry domination - 4 months ago
5	James Brumley Motley Fool	Is Recursion Pharmaceuticals a Millionaire-Maker Stock? - about 2 months ago
6	Umesh Ellichipuram Power Technology Resources for power, energy industries. Worldwide Powerenergy	Recurrent Energy signs two tolling agreements with APS - about 2 months ago
7	JP Casey PV Tech In-depth PV news source. London, United Kingdom solar PVsupply chainin-depth news	US ROUND-UP: Sabanci, Origis and Recurrent secure finance, National Grid Renewables and Microsoft sign PPA - 3 months ago Recurrent Energy unveils US$100 million in funding for 300MW Ciranda solar project in Brazil - about 1 year ago Recurrent raises US$200 million for Liberty solar project in Texas - over 1 year ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 4 months ago
9	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Summit’s upcoming cancer results, Recursion’s mixed data, and the next big obesity target - 4 months ago
10	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Postpartum Readmissions Up With High Blood Pressures Lingering From Pregnancy - 7 months ago Colchicine Not the Answer for Recurring Arrhythmias After Ablation - about 1 year ago

Journalists covering recurrent